<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
      <PMID Version="1">35071530</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>01</Month>
        <Day>25</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Print">2307-8960</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>10</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>World journal of clinical cases</Title>
          <ISOAbbreviation>World J Clin Cases</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Bilateral Hypertrophic Olivary Degeneration after Pontine Hemorrhage: A Case Report.</ArticleTitle>
        <Pagination>
          <StartPage>289</StartPage>
          <EndPage>295</EndPage>
          <MedlinePgn>289-295</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.12998/wjcc.v10.i1.289</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Hemorrhage lesions may lead to bilateral hypertrophic olivary degeneration (HOD) through interruption of the dentato-rubral-olivary pathway. The pathological features of HOD are unusual neuronal trans-synaptic degenerative changes.</AbstractText>
          <AbstractText Label="CASE SUMMARY" NlmCategory="METHODS">A 56-year-old female was admitted to our hospital because her lower extremities and left upper ones were unable to move for 3 mo, and the swelling of her right lower extremities became worse 3 days ago. She had a hypertension history. Her characteristic clinical manifestations are palatal myoclonus and nystagmus. The patient's magnetic resonance imaging (MRI) results showed that she had bilateral HOD after an acute pontine hemorrhage. She was given symptomatic and supportive treatment. The gabapentin, the memantine and the trihexyphenidyl were taken twice a day each. The rehabilitation and psychotherapy were implemented. After 3 months of treatment, her eye symptoms improved.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Bilateral HOD is a rare phenomenon after pontine hemorrhage. The key to diagnosis lies in the clinical manifestations and MRI results.</AbstractText>
          <CopyrightInformation>©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Zheng</LastName>
            <ForeName>Bo</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Yaan People's Hospital, Yaan 625000, Sichuan Province, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Jian</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Yaan People's Hospital, Yaan 625000, Sichuan Province, China. wangjian0724@126.com.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Huang</LastName>
            <ForeName>Xue-Qiong</ForeName>
            <Initials>XQ</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Oncology, Yaan People's Hospital, Yaan 625000, Sichuan Province, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chen</LastName>
            <ForeName>Zhao</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Yaan People's Hospital, Yaan 625000, Sichuan Province, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gu</LastName>
            <ForeName>Gang-Feng</ForeName>
            <Initials>GF</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Yaan People's Hospital, Yaan 625000, Sichuan Province, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Luo</LastName>
            <ForeName>Xiao-Jing</ForeName>
            <Initials>XJ</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Yaan People's Hospital, Yaan 625000, Sichuan Province, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D002363">Case Reports</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>World J Clin Cases</MedlineTA>
        <NlmUniqueID>101618806</NlmUniqueID>
        <ISSNLinking>2307-8960</ISSNLinking>
      </MedlineJournalInfo>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Case report</Keyword>
        <Keyword MajorTopicYN="N">Dentato-rubral-olivary pathway</Keyword>
        <Keyword MajorTopicYN="N">Hypertrophic olivary degeneration</Keyword>
        <Keyword MajorTopicYN="N">Magnetic resonance imaging</Keyword>
        <Keyword MajorTopicYN="N">Pontine hemorrhage</Keyword>
        <Keyword MajorTopicYN="N">Quadriplegia</Keyword>
      </KeywordList>
      <CoiStatement>Conflict-of-interest statement: The authors declare that they have no conflict of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>5</Month>
          <Day>10</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>9</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>29</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>24</Day>
          <Hour>8</Hour>
          <Minute>55</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>25</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>25</Day>
          <Hour>6</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35071530</ArticleId>
        <ArticleId IdType="pmc">PMC8727256</ArticleId>
        <ArticleId IdType="doi">10.12998/wjcc.v10.i1.289</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Goyal M, Versnick E, Tuite P, Cyr JS, Kucharczyk W, Montanera W, Willinsky R, Mikulis D. Hypertrophic olivary degeneration: metaanalysis of the temporal evolution of MR findings. AJNR Am J Neuroradiol. 2000;21:1073–1077.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7973904</ArticleId>
            <ArticleId IdType="pubmed">10871017</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Carr CM, Hunt CH, Kaufmann TJ, Kotsenas AL, Krecke KN, Wood CP. Frequency of bilateral hypertrophic olivary degeneration in a large retrospective cohort. J Neuroimaging. 2015;25:289–295.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24716899</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Marden FA. Hypertrophic olivary degeneration due to pontine hemorrhage. JAMA Neurol. 2013;70:1330.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23921433</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Menezes Cordeiro I, Tavares JB, Reimão S, Geraldes R, Ferro JM. Hypertrophic olivary degeneration after pontine hemorrhage: a cause of delayed neurological deterioration. Cerebrovasc Dis. 2013;36:153–154.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24029616</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tilikete C, Desestret V. Hypertrophic Olivary Degeneration and Palatal or Oculopalatal Tremor. Front Neurol. 2017;8:302.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5490180</ArticleId>
            <ArticleId IdType="pubmed">28706504</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pandey P, Westbroek EM, Gooderham PA, Steinberg GK. Cavernous malformation of brainstem, thalamus, and basal ganglia: a series of 176 patients. Neurosurgery. 2013;72:573–89; discussion 588.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23262564</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dogan SN. Hypertrophic Olivary Degeneration and Holmes Tremor: Case Report and Review of the Literature. World Neurosurg. 2020;137:286–290.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32084623</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gatlin JL, Wineman R, Schlakman B, Buciuc R, Khan M. Hypertrophic olivary degeneration after resection of a pontine cavernous malformation: a case report. J Radiol Case Rep. 2011;5:24–29.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3303435</ArticleId>
            <ArticleId IdType="pubmed">22470783</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Akar S, Drappatz J, Hsu L, Blinder RA, Black PM, Kesari S. Hypertrophic olivary degeneration after resection of a cerebellar tumor. J Neurooncol. 2008;87:341–345.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18217209</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Macht S, Hänggi D, Turowski B. Hypertrophic olivary degeneration following pontine cavernoma hemorrhage: a typical change accompanying lesions in the Guillain-Mollaret triangle. Klin Neuroradiol. 2009;19:235–237.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19727585</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gerace C, Fele MR, Luna R, Piazza G. Neurological picture. Bilateral hypertrophic olivary degeneration. J Neurol Neurosurg Psychiatry. 2006;77:73.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2117422</ArticleId>
            <ArticleId IdType="pubmed">16361597</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang J, Yang J, Li B, Bao L. Transient Palatal Tremor and Action Induced Foot and Leg Dystonia due to Hypertrophic Olivary Degeneration: a Case Report. J Stroke Cerebrovasc Dis. 2020;29:105147.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32912540</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lapresle J. Rhythmic palatal myoclonus and the dentato-olivary pathway. J Neurol. 1979;220:223–230.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8331536</ArticleId>
            <ArticleId IdType="pubmed">90131</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bird K, Saint-Hilaire M, Curiale G, O'Shea SA. Development of Hypertrophic Olivary Degeneration following Pontine Hemorrhage. Ann Neurol. 2020;87:809–810.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32339325</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Suner M, Prusky GT, Carmel JB, Hill NJ. Longitudinal Quantification of Eye-Movement Impairments after Pontine Hemorrhage. Front Neurol. 2017;8:165.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5411421</ArticleId>
            <ArticleId IdType="pubmed">28512444</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Onen MR, Moore K, Cikla U, Ucer M, Schmidt B, Field AS, Baskaya MK. Hypertrophic Olivary Degeneration: Neurosurgical Perspective and Literature Review. World Neurosurg. 2018;112:e763–e771.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29382617</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
